Related Experiment Video
Updated: Aug 3, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy
1Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. amarian@bcm.tmc.edu
Insights
Cardiac myocyte contractility is decreased in hypertrophic cardiomyopathy, not increased. This contractile deficit stimulates factors leading to hypertrophy and fibrosis, explaining disease variability.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is characterized by cardiac hypertrophy.
- Current understanding suggests increased myocardial contractility in HCM.
- This study proposes an alternative hypothesis for HCM pathogenesis.
Purpose of the Study:
- To challenge the prevailing view of increased contractility in HCM.
- To propose that decreased cardiac myocyte contractility is the primary defect in HCM.
- To link this contractile deficit to the expression of cardiac trophic factors and subsequent phenotypes.
Main Methods:
- Review of existing literature and proposed hypothesis.
- Analysis of gene transfer studies in cardiac myocytes from HCM patients.
- Conceptual framework linking contractility, trophic factors, and HCM phenotypes.
Main Results:
- Gene transfer studies support impaired contractility and increased trophic factor expression in HCM myocardium.
- Hypothesis posits that contractile deficit drives trophic factor increase, leading to hypertrophy and fibrosis.
- Individual variations in trophic factor expression explain phenotypic variability in HCM.
Conclusions:
- Decreased cardiac myocyte contractility may be the primary driver of HCM.
- Trophic factors, stimulated by contractile deficits, are key mediators of HCM phenotypes.
- Further research is needed to measure myocyte contractility, identify trophic factors, and test inhibition strategies in HCM.
Abstract:
Myocardial contractility is generally believed to be increased in hypertrophic cardiomyopathy. I propose the opposite--that cardiac myocyte contractility is decreased in this disorder. Accordingly, the contractile deficit provides the primary stimulus for increased expression of trophic factors in the heart, which leads to hypertrophy, interstitial fibrosis, and other phenotypes. Variation among individuals in expression of trophic factors would account for the variability of phenotypes. Gene transfer studies in cardiac myocytes showing impaired contractility and increased expression of trophic factors in the myocardium of patients with hypertrophic cardiomyopathy support this hypothesis. Testing of the hypothesis would require measurement of contractility of cardiac myocytes isolated from patients with hypertrophic cardiomyopathy, identification of the main trophic factors in the hearts of these patients, and investigation of whether their inhibition can prevent or lead to regression of the cardiac phenotypes.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

